THE ARTIFICIAL CARDIAC PACEMAKER. INDICATIONS FOR IMPLANTATION.
Extensive clinical experience has demonstrated that implantable cardiac pacemakers are safe and effective mechanisms for controlling symptoms and preventing the hazards of third degree heart block with Stokes-Adams syncope. Medical management of this disease does not provide reliable protection and life expectancy averages about two years after diagnosis. Hence the negligible surgical morbidity and mortality associated with pacemaker implantation justifies broad indications to implant one of the four commercially available battery-powered units. ELECTIVE IMPLANTATION OF A PACEMAKER SHOULD BE CONSIDERED IN PATIENTS WITH PERSISTENT THIRD DEGREE HEART BLOCK WHO HAVE HAD: One or more episodes of Stokes-Adams syncope; surgical injury to the conduction system, regardless of syncopal attacks; evidence of low cardiac output with cardiomegaly secondary to bradycardia. Few if any other cardiac arrythmias are satisfactorily controlled by an electrical pacemaker. Emergency pacemaker control is obviously necessary for patients developing intractable or recurrent bouts of asystole. During the interval until an implantable unit can be obtained and sterilized, the patient may be controlled by intravenous isoproterenol or by an external pacemaker attached to a transvenous catheter electrode, a precordial skin electrode or a percutaneous myocardial wire electrode.
D000219:Adams-Stokes Syndrome; D001145:Arrhythmias, Cardiac; D054537:Atrioventricular Block; D001919:Bradycardia; D053840:Brugada Syndrome; D000075224:Cardiac Conduction System Disease; D002303:Cardiac Output, Low; D006332:Cardiomegaly; D004566:Electrodes; D006323:Heart Arrest; D006329:Heart Conduction System / Q000002:abnormalities; D006801:Humans; D007545:Isoproterenol; D009206:Myocardium; D010138:Pacemaker, Artificial; D013575:Syncope
D007545:Isoproterenol
ADAMS-STOKES SYNDROME; PACEMAKER, ARTIFICIAL